A Preliminary Analysis of China's Pharmacovigilance System
Since 2019,China has implemented a pharmacovigilance system,representing a reform and innovation based on the adverse drug reaction reporting and monitoring system,marking the steady improvement of China's drug supervision level.However,it should be noted that China's pharmacovigilance system still faces many challenges,mainly reflected in the need for improvement in the legislation system,organizational system,and technical system.Based on the current status of the pharmacovigilance system in China,this paper proposes feasible paths to improve the system by improving legislation,establishing a scientific organization system,strengthening the technical system,adopting a"one and two wings"monitoring mode,and promoting multi-stakeholder collaborative governance.These measures aim to ensure public drug safety and maintain public health security.
drug administration lawpharmacovigilanceadverse drug reaction monitoringsystem
万方数据
维普
